 MENLO PARK, Calif., July 12, 2021 GLOBE NEWSWIRE -- 180 Life Sciences Corp. NASDAQ: ATNF 180 Life Sciences or the Company, a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced today that it has regained Nasdaq Compliance for Listing Rules 5605b1 and 5605c2. 